Durata Therapeutics, Inc. Business Combination, Contingent Consideration, Liability
Durata Therapeutics, Inc. had Business Combination, Contingent Consideration, Liability of $25.00 million as of 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2014-11-07
- 2014-06-30: Business Combination, Contingent Consideration, Liability $25.00M.
- 2014-03-31: Business Combination, Contingent Consideration, Liability $23.59M.
- 2013-12-31: Business Combination, Contingent Consideration, Liability $20.89M.
- 2013-09-30: Business Combination, Contingent Consideration, Liability $20.67M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2014-06-30 | $25.00M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $23.59M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $20.89M 10-Q · filed 2014-11-07 |
| 2013-09-30 | $20.67M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $20.41M 10-Q · filed 2013-08-07 |
| 2012-12-31 | $19.84M 10-K · filed 2014-03-14 |
| 2009-12-11 | $5.80M 10-K · filed 2014-03-14 |